MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB

Overview of attention for article published in Clinical Cancer Research, December 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 10,206 followers.

Targeting the melanosome via #gpnmb with #glembatumumab #cdx011 a viable strategy to improve treatment for #melanoma https://t.co/cDD9LW9mJh

MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB https://t.co/bLQPdZkyDl

MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB https://t.co/LwmklR7hCz

MAPK Pathway Inhibitors Sensitize BRAF Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB https://t.co/vL11b6wp5n

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.